Edwards Lifesciences (EW)☆

Edwards Lifesciences specializes in heart-valve and critical-care devices. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

Edwards Lifesciences trades on the NYSE under the ticker symbol EW. As of the most recent market data, the stock was priced around $85.73, down 2.40% on the session, giving Edwards Lifesciences a market capitalization of roughly $49.36B.

Over the past 52 weeks, EW has traded between $72.30 and $96.29. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 47.4, a common gauge of how richly the market prices the company's earnings.

As one of the larger companies in the Health Care sector, Edwards Lifesciences is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch EW for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.